Kessler Investment Group, LLC Anavex Life Sciences Corp. Transaction History

Kessler Investment Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$16.82 - $25.75 $50,460 - $77,250	-3,000 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$10.16 - $28.86 $30,480 - $86,580	3,000 New	3,000 $69,000
Q3 2020 Oct 14, 2020	SELL	$3.8 - $5.0 $9,500 - $12,500	-2,500 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$2.62 - $5.2 $37,914 - $75,249	-14,471 Reduced 85.27%	2,500 $12,000
Q1 2020 Apr 22, 2020	SELL	$2.38 - $5.81 $8,925 - $21,787	-3,750 Reduced 18.1%	16,971 $53,000
Q3 2019 Oct 21, 2019	BUY	$2.22 - $3.9 $37,120 - $65,211	16,721 Added 418.03%	20,721 $65,000
Q1 2019 Apr 16, 2019	BUY	$1.68 - $3.42 $6,720 - $13,680	4,000 New	4,000 $12,000

202

31.3M

1.32M

662K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $840M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Kessler Investment Group, LLC with notifications on news.